AR018869A1 - Composicion farmaceutica, su uso para la preparacion de medicamentos y estuche que la contiene - Google Patents

Composicion farmaceutica, su uso para la preparacion de medicamentos y estuche que la contiene

Info

Publication number
AR018869A1
AR018869A1 ARP990102848A ARP990102848A AR018869A1 AR 018869 A1 AR018869 A1 AR 018869A1 AR P990102848 A ARP990102848 A AR P990102848A AR P990102848 A ARP990102848 A AR P990102848A AR 018869 A1 AR018869 A1 AR 018869A1
Authority
AR
Argentina
Prior art keywords
compositions
medicines
preparation
case
pharmaceutical composition
Prior art date
Application number
ARP990102848A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR018869A1 publication Critical patent/AR018869A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Se describen composiciones farmacéuticas de combinacion y procedimientos que contienen (-)-cis-6-fenil-5-(4-(2-pirrolidin-1-il-etoxi)fenil)-5,6.7,8-tetrahidronaftalen-2-ol o una de sus sales farmacéuticamente aceptables y 2-amino-N-(2-(3a(R)-bencil-2-metil-3-oxo-2,3,3a,4,6,7-hexahidro-pirazolo[4,3-c]piridin-5-il)-1(R)-benciloximetil-2-oxo-etil)-isobutiramida o una de sus sales farmacéuticamente aceptables, a procedimientos para usar tales composiciones ya estuches que contienen tales composiciones. Las composiciones son de utilidad para tratar fragilidad musculoesquelética, incluyendo osteoporosis, fracturaosteoporotica, masa osea reducida, fragilidad y masa muscular reducida.
ARP990102848A 1998-06-16 1999-06-15 Composicion farmaceutica, su uso para la preparacion de medicamentos y estuche que la contiene AR018869A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8946998P 1998-06-16 1998-06-16

Publications (1)

Publication Number Publication Date
AR018869A1 true AR018869A1 (es) 2001-12-12

Family

ID=22217825

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990102848A AR018869A1 (es) 1998-06-16 1999-06-15 Composicion farmaceutica, su uso para la preparacion de medicamentos y estuche que la contiene

Country Status (30)

Country Link
EP (1) EP1087764A1 (es)
JP (1) JP2002518326A (es)
KR (1) KR20010052852A (es)
CN (1) CN1301160A (es)
AP (1) AP9901582A0 (es)
AR (1) AR018869A1 (es)
AU (1) AU4054799A (es)
BG (1) BG105041A (es)
BR (1) BR9911324A (es)
CA (1) CA2335134A1 (es)
CO (1) CO5070587A1 (es)
EA (1) EA200001186A1 (es)
GT (1) GT199900087A (es)
HN (1) HN1999000097A (es)
HR (1) HRP20000859A2 (es)
HU (1) HUP0102505A3 (es)
ID (1) ID27599A (es)
IL (1) IL138630A0 (es)
IS (1) IS5691A (es)
MA (1) MA26652A1 (es)
NO (1) NO20006312D0 (es)
OA (1) OA11505A (es)
PA (1) PA8475901A1 (es)
PE (1) PE20000646A1 (es)
PL (1) PL344981A1 (es)
SK (1) SK18912000A3 (es)
TN (1) TNSN99124A1 (es)
TR (1) TR200003544T2 (es)
WO (1) WO1999065486A1 (es)
ZA (1) ZA993975B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2360103A1 (en) * 1999-02-08 2000-08-17 Robert Sladek Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding orphan nuclear receptor erralpha
ES2274854T3 (es) 2000-05-08 2007-06-01 Pfizer Products Inc. Resolucion enzimatica de moduladores selectivos del receptor de estrogeno.
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
CA2420535A1 (en) * 2000-08-30 2002-03-07 Mary Tanya Am Ende Sustained release formulations for growth hormone secretagogues
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2006024931A2 (en) * 2004-08-31 2006-03-09 Pfizer Products Inc. Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
CN101657436A (zh) 2007-02-09 2010-02-24 特兰齐姆制药公司 大环生长素释放肽受体调节剂及其使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
HUP0102505A2 (hu) 2001-11-28
IL138630A0 (en) 2001-10-31
HRP20000859A2 (en) 2001-04-30
CO5070587A1 (es) 2001-08-28
NO20006312L (no) 2000-12-12
AP9901582A0 (en) 1999-06-30
MA26652A1 (fr) 2004-12-20
JP2002518326A (ja) 2002-06-25
TNSN99124A1 (fr) 2005-11-10
KR20010052852A (ko) 2001-06-25
PE20000646A1 (es) 2000-08-05
SK18912000A3 (sk) 2001-10-08
TR200003544T2 (tr) 2001-04-20
PL344981A1 (en) 2001-11-19
ZA993975B (en) 2000-12-15
CA2335134A1 (en) 1999-12-23
NO20006312D0 (no) 2000-12-12
ID27599A (id) 2001-04-12
AU4054799A (en) 2000-01-05
HN1999000097A (es) 1999-11-03
WO1999065486A1 (en) 1999-12-23
BG105041A (en) 2001-08-31
PA8475901A1 (es) 2000-05-24
OA11505A (en) 2004-05-07
CN1301160A (zh) 2001-06-27
EP1087764A1 (en) 2001-04-04
IS5691A (is) 2000-10-27
HUP0102505A3 (en) 2002-12-28
BR9911324A (pt) 2001-04-03
GT199900087A (es) 2000-12-07
EA200001186A1 (ru) 2001-06-25

Similar Documents

Publication Publication Date Title
HUP0401293A2 (hu) Új dihidropteridinonok, eljárás előállításukra és alkalmazásuk gyógyszerként
NO20021448L (no) Nye tiazolo-(4,5-D)pyrimidinforbindelser
AR035792A1 (es) Compuestos de n-(4-quinazolinil)-n-(1h-indazol-5-il) amina, inhibidor de la rho-quinasa, su uso para la fabricacion de un medicamento y metodo para prepararlo
HUP0301562A2 (hu) Új oxazolidinonszármazékok és eljárás ezek előállítására, ezeket tartalmazó gyógyszerkészítmények
IL145430A0 (en) N-cyanomethyl amides, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0303082A2 (hu) Szubsztituált indolil-oxo-acetil-piperazinszármazékok, ezeket tartalmazó készítmények és vírusellenes alkalmazásuk
FR2755967B1 (fr) Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments
HRP20060387A2 (en) Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
PT991653E (pt) Novos compostos
PT1263730E (pt) Derivados amina para o tratamento de apoptose
HUP0300385A2 (hu) Aszpartil-proteáz inhibitorok
NO993027D0 (no) Pyrrolo[3,4-D]pyrimidinonderivater og deres anvendelse som legemidler
AR018869A1 (es) Composicion farmaceutica, su uso para la preparacion de medicamentos y estuche que la contiene
ATE440838T1 (de) Pharmazeutisch aktive sulfonylaminosäurederivate
AR018867A1 (es) Composicion farmaceutica, uso de la composicion, estuche, uso de los compuestos para preparar la composicion y el estuche
AR018868A1 (es) Composiciones farmaceuticas para la fragilidad musculoesqueletica, uso para la preparacion de medicamentos, estuche
MXPA04005552A (es) Analogos de vitamina d.
NO995685D0 (no) Nye glycosylerte ginkgolidderivater, anvendelse derav som medikamenter og farmasöytiske blandinger
DK1525188T3 (da) Hidtil ukendte derivater af 4,4-dithiobis-(3-aminobutan-1-sulfonater) og sammensætninger, der indeholder dem
IL131216A (en) Drugs inhibiting progress of pterygium and postoperative recurrence of the same
NO305082B1 (no) 2-(4-(4-azolbutyl)-1-piperazinyl)-5-hydroksy-pyrimidinderivater, deres fremstilling og anvendelse som legemidler
NO880406L (no) 5-(3-alkyl-5-tert-butyl-4-hydroksyfenyl)-2-amino-6h-1,3,4-tiadiaziner, fremgangsmaate til deres fremstilling og legemidler som inneholder dem og deres anvendelse.
HUP0004701A2 (hu) Új dezloratadin sók, az ezeket tartalmazó gyógyászati készítmények és eljárás azok előállítására
HUP0105235A2 (hu) Az N-terminálison szubsztituált benzilcsoportot tartalmazó bisz-aminosav szulfonamidok mint HIV proteáz inhibitorok, azokat tartalmazó gyógyászati készítmények és alkalmazásuk
ECSP993020A (es) Terapia de combinacion para la fragilidad musculoesqueletica

Legal Events

Date Code Title Description
FA Abandonment or withdrawal